Evidence map›Paper›PMID 34924384›Full record

ArticleJournal of Alzheimer's disease : JAD2022

A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks.

Hannah J Kimmel, Deborah A Levine, Rachael T Whitney, Jane Forman, Brenda L Plassman, Angela Fagerlin, Kathleen Anne Welsh-Bohmer, Bailey K Reale, Andrzej T Galecki, Emilie Blair and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Influence of mild cognitive impairment on patient and care partner decision-making for acute ischemic stroke.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Hannah J KimmelDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Deborah A LevineDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Rachael T WhitneyDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Jane FormanDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Brenda L PlassmanDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Angela FagerlinDepartment of Population Health Sciences, UT and Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS 2.0) Center for Innovation, University of Utah, Salt Lake City, UT, USA.
Kathleen Anne Welsh-BohmerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Bailey K RealeDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Andrzej T GaleckiDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Emilie BlairDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Kenneth M LangaDepartment of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Bruno GiordaniDepartment of Psychiatry & Michigan Alzheimer's Disease Center, U-M, Ann Arbor, MI, USA.
Colleen KollmanKollman Research Services, Ann Arbor, MI, USA.
Jing WangFudan University School of Nursing, Shanghai, China.
Darin B ZahuranecDepartment of Neurology and Stroke Program, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USDuke University · USClinical Research Services · DEFudan University · CNPrevent Alzheimer’s Disease 2020 · USUniversity of Utah · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive ImpairmentR01AG051827 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVINE, DEBORAH ALLISON · 2016 to 2020
$3.6M
NCATS NIH HHS UL1 TR002240NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG051827
6 · The paper itself

Abstract

backgroundOlder patients (≥65 years) with mild cognitive impairment (MCI) are undertreated for cardiovascular disease (CVD). One reason for this disparity could be that patients with MCI might underestimate the chances of CVD and overestimate dementia.

objectiveTo compare conceptions of health risk between older patients with MCI and normal cognition (NC) and their care partners.

methodsWe conducted a multi-center mixed-methods study of patient-care partner dyads completing written quantitative surveys (73% response rate; 127 dyads: 66 MCI and 61 NC) or semi-structured interviews (20 dyads: 11 MCI, and 9 NC). Surveys assessed two-year patient risks of dementia, heart attack, stroke, and fall. Interviews assessed similar health risks and reasons for risk perceptions.

resultsOn surveys, a similarly low proportion of MCI and NC patients felt they were at risk of stroke (5% versus 2%; p = 0.62) and heart attack (2% versus 0%; p = 0.99). More MCI than NC patients perceived dementia risk (26% versus 2%; p < 0.001). Care partners' survey findings were similar. Interviews generally confirmed these patterns and also identified reasons for future health concerns. For both MCI and NC dyads, personal experience with cognitive decline or CVD (personal or family history) increased concerns about each disease. Additionally, perceptions of irreversibility and lack of treatment for cognitive decline increased concern about dementia.

conclusionLess use of CVD treatments in MCI seems unlikely to be driven by differential perceptions of CVD risk. Future work to improve awareness of CVD risks in older patients and dementia risk in patients with MCI are warranted.

Indexed as

Cognitive DysfunctionHeart Disease Risk FactorsPerceptionAgedAged, 80 and overCaregiversFemaleHumansMaleSurveys and QuestionnairesDementiafamily caregiversheart disease risk factorsmild cognitive impairmentrisk assessment

Identifiers

PMID34924384
PMCPMC8969329
OpenAlexW4200055351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.